GIP ANALOG AND HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

The present invention relates generally to novel GIP analogs and GIP hybr id polypeptides with selectable properties, useful as agents for the treatme nt and prevention of metabolic diseases and disorders, for example those whi ch can be alleviated by control plasma glucose levels, insulin levels, a...

Full description

Saved in:
Bibliographic Details
Main Authors LEWIS, DIANA Y, SOARES, CHRISTOPHER J, SRIVASTAVA, VED, YOUNG, ANDREW A, LE, THAO, MACK, CHRISTINE M, HANLEY, MICHAEL R, GHOSH, SOUMITRA G, PITTNER, RICHARD A, JODKA, CAROLYN M, ERICKSON, MARY, BARON, ALAIN D, JANSSEN, SAMUEL, LEVY, ODILE ESTHER, D'SOUZA, LAWRENCE J, PARKES, DAVID G
Format Patent
LanguageEnglish
French
Published 21.02.2008
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates generally to novel GIP analogs and GIP hybr id polypeptides with selectable properties, useful as agents for the treatme nt and prevention of metabolic diseases and disorders, for example those whi ch can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, positive inotropic effects, reduction of catabolic effe cts, slowing of gastric emptying. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eat ing disorders, critical care, insulin-resistance, obesity, and diabetes mell itus of any kind, including type 1, type 2, and gestational diabetes.
Bibliography:Application Number: CA20072660835